# Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

> **NCT02213822** · — · UNKNOWN · sponsor: **Rhode Island Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Solid Tumors
- Hematological Malignancies

## Interventions

- **OTHER:** Molecular Analysis of Cancer

## Key facts

- **NCT ID:** NCT02213822
- **Lead sponsor:** Rhode Island Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2014-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02213822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02213822, "Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02213822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*